Your Tears Could Be Hiding Clues About Your Brain Health

A tear is easy to overlook. It appears when we cry, blink, laugh too hard, or face a cold wind. But researchers are exploring whether this tiny drop of fluid could carry something far more useful than emotion: early clues about neurological health.

The question is both simple and intriguing. Could a quick, painless tear sample someday help doctors monitor changes in the brain before major symptoms appear?

Image Credit: Motortion Films via Shutterstock

A research team reporting in ACS Omega has taken a step toward that possibility by developing a low-cost electrochemical sensor that can detect dopamine in artificial human tears. Dopamine is a neurotransmitter involved in movement, learning, motivation, and emotional regulation. When dopamine levels shift too far from normal, those changes can be linked to neurological and psychiatric conditions, including Parkinson’s disease.

Why Look for Brain Clues in Tears?

Monitoring dopamine is not always simple. Current methods can involve blood samples, urine analysis, or implanted devices. These approaches may take time, require lab processing, or involve invasive procedures.

Tears offer a very different possibility. They can be collected quickly and without pain, making them an appealing source of health information. According to the release, researchers wanted to explore whether tears could provide a noninvasive way to monitor dopamine levels.

That matters because dopamine changes are associated with several health conditions. In Parkinson’s disease, for example, dopamine concentrations tend to decrease. Detecting such changes earlier could open the door to closer monitoring and potentially earlier care.

By creating the sensor, “we aim to facilitate the ultra-early detection of neurological disorders, creating opportunities for clinical interventions before major symptoms manifest,” says corresponding author Neftalí Lênin Villarreal Carreño.

How a Postage-Stamp-Sized Sensor Spots Dopamine

To build the device, the researchers started with a thin plastic film. They used a laser to convert parts of the film into electrically conductive graphene, a material that can interact with dopamine.

The finished sensor is about the size of a postage stamp. When dopamine reacts with the graphene, the device produces an electrical signal. That signal allows the researchers to detect and measure dopamine in a sample.

In laboratory tests, the team added dopamine to artificial human tears and measured how well the sensor performed. The device accurately detected a range of dopamine concentrations. Importantly, it also identified levels similar to those previously reported in tears from people with Parkinson’s disease.

The sensor continued to work even when other compounds commonly found in tears were present. That is an important detail because real biological samples are complex. A useful sensor needs to identify the target substance without being confused by everything else around it.

What This Could Mean for Future Monitoring

The researchers are not saying this sensor is ready for routine clinical use. The tests described in the release were done with artificial human tears, not tear samples from patients. But the results establish a foundation for the next stage: studies using human tear samples.

The goal is to support the development of point-of-care devices that could monitor neurological biomarkers through a simple tear sample. In the future, such tools could help track conditions linked to atypical dopamine levels, including Parkinson’s disease.

“Our sensor can detect dopamine from levels well below the healthy baseline and up to three times higher,” says coauthor Lucas Minghini Gonçalves. “This capability ensures that a person’s initial dopamine drop can be identified early on, which is crucial to enabling timely, proactive therapeutic interventions.”

For now, the work points to a promising idea rather than a finished medical product. A few tears may one day help reveal important clues about neurological health, not by replacing doctors or existing tests, but by offering a simpler, less invasive way to see changes that are otherwise hard to catch early.

If you are interested in more details about the underlying research have a look at the paper published in ACS Omega listed below.

Sources and further reading:


Too busy to follow science news during the week? - Consider subscribing to our (free) newsletter - (Universal-Sci Weekly) - and get the 5 most interesting science articles of the week in your inbox


FEATURED ARTICLES: